Expanding Genetic Testing Predictive Laboratories has launched innovative genetic testing services such as FertilityDX and ARTguide, indicating a strong market focus on fertility and women’s health diagnostics. Opportunities exist to provide complementary lab equipment, reagents, and data management solutions to enhance their testing capabilities.

Strategic Industry Collaborations The company's partnerships with industry leaders like Thermo Fisher Scientific and the Preeclampsia Foundation highlight its commitment to research and development. This opens avenues for selling advanced genomics instruments, research tools, and analytical software to support their collaborative projects.

Investment in Technical Capacity Recent investments of $6 million in genomics equipment suggest an ongoing effort to scale technical capacity. Selling next-generation sequencing machines, laboratory automation systems, or high-throughput genotyping platforms could align with their expansion plans.

Focus on Women’s Health With leadership hires in women’s health and targeted development of diagnostics for conditions like endometriosis and preeclampsia, the company is positioned for growth in specialized diagnostics. Opportunities include marketing advanced medical devices, sample collection systems, and data analytics tools tailored for women's reproductive health clinics.

Market Expansion Potential Although revenue remains under $1 million, the company's recent product launches and research initiatives position it for scale. Offering scalable laboratory solutions, clinical data management systems, or regulatory consulting services could facilitate their market expansion and increase revenue streams.